Millions of people in the United States with mental health conditions are newly eligible for COVID-19 vaccine booster shots. The Centers for Disease Control and Prevention has added mood disorders to its list of health conditions that put people at risk for severe...
ust in time for Thanksgiving gatherings, several kinds of rapid COVID tests you can take home are hitting the market. Some give results within minutes, and soon they will be able to test for both COVID and the flu. Looking to other countries, this could be the...
Treatment with once-daily single-inhaler fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) triple therapy appears to be more efficacious in reducing severe exacerbations in patients with chronic obstructive pulmonary disease (COPD) than the standard...
Register today for Princeton’s annual innovation and entrepreneurship conference. Join fellow innovators to make connections and discover your own opportunities – through industry intersections, entrepreneurship, transformational research and Princeton’s...
Since COVID-19 reared its ugly head more than 18 months ago, public health experts have longed to bolster their pandemic toolbox with a pill that could easily treat coronavirus. They may finally have one. Fluvoxamine, an off-patent, widely available antidepressant,...
